JPET Celsis microsomes equal better data

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Burns, J. J.
Right arrow Articles by Brodie, B. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Burns, J. J.
Right arrow Articles by Brodie, B. B.
Journal of Pharmacology And Experimental Therapeutics, Vol. 108, Issue 1, 33-41, 1953
Copyright © 1953 by American Society for Pharmacology and Experimental Therapeutics


THE BIOTRANSFORMATION OF ETHYL BISCOUMACETATE (TROMEXAN) IN MAN, RABBIT AND DOG

J. J. Burns 1, Murray Weiner 1, George Simson 1, and Bernard B. Brodie 2

1 Third (New York University) Medical Division, Goldwater Memorial Hospital, New York, New York
2 Laboratory of Chemical Pharmacology, National Heart Institute, National Institutes of Health, Public Health Service, Federal Security Agency, Bethesda, Maryland

1. Tromexan undergoes almost complete metabolic transformation in man. An important route of metabolism involves hydroxylation of one of the benzene rings. The metabolite, hydroxy-Tromexan, reaches the urine by a circuitous route; it is formed in the liver and secreted into the bile; it then passes into the intestine, and after absorption into the bloodstream is finally excreted in the urine. This accounts for the long delay before the metabolite appears in the urine; most of the administered Tromexan has disappeared from the body before the metabolite appears in the urine. There is no evidence for the hydrolysis of Tromexan in man to the corresponding acid, Tromexan acid.

2. Hydroxy-Tromexan does not affect the prothrombin activity of plasma in mice.

3. In the rabbit Tromexan is metabolized at about the same rate as in man, but by de-esterification rather than by hydroxylation.

4. In the dog, Tromexan is metabolized at a rate of about 3 per cent per hour, compared to about 20 per cent per hour in man and rabbit.

Submitted on December 3, 1952







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1953 by the American Society for Pharmacology and Experimental Therapeutics.